Clinical Trials on Non Follicular Indolent Non-Hodgkin Lymphoma
Total 4837 results
-
The Lymphoma Academic Research OrganisationTerminated
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineTerminatedFollicular LymphomaUnited States
-
Sunnybrook Health Sciences CentreCompletedFollicular LymphomaCanada
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompleted
-
Hoffmann-La RocheCompleted
-
St. Louis UniversityCompletedFollicular LymphomaUnited States
-
Charite University, Berlin, GermanyUnknownFollicular Lymphoma
-
Fondazione Italiana Linfomi ONLUSUnknown
-
Weill Medical College of Cornell UniversityCompletedHodgkins Disease | Lymphoma, Non-HodgkinsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
University of BirminghamCancer Research UK; GenmabRecruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited Kingdom
-
Georgetown UniversityAbbVie; Pharmacyclics LLC.; Hackensack Meridian HealthActive, not recruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineWithdrawnLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, B-Cell, Marginal Zone | Lymphoma, Low-Grade | Lymphoma, Intermediate-Grade
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma and other conditionsUnited States
-
European Hematology Association - Lymphoma GroupAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Associazione...RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular LymphomaSpain, Netherlands, Italy, Croatia, Portugal, Ukraine
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; Pharmacyclics LLC.TerminatedFollicular Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade IIIaUnited States
-
National Cancer Institute (NCI)TerminatedLeukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory... and other conditionsUnited States
-
Juventas Cell Therapy Ltd.Not yet recruiting
-
Sun Yat-sen UniversityRecruitingNon-hodgkin LymphomaChina
-
Swiss Group for Clinical Cancer ResearchTerminatedNon-Hodgkin LymphomaSwitzerland
-
Gilead SciencesTerminatedNon-Hodgkin LymphomaUnited States, France
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Genzyme, a Sanofi CompanyCompletedHodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Hospices Civils de LyonActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaFrance
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingFollicular LymphomaUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; Genentech, Inc.Recruiting
-
Fondazione Italiana Linfomi - ETSRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Follicular LymphomaUnited States
-
Ruijin HospitalRecruiting
-
National Cancer Institute (NCI)Recruiting
-
XEME Biopharma Inc.Not yet recruitingFollicular LymphomaUnited States
-
Hoffmann-La RocheActive, not recruitingFollicular LymphomaUnited Kingdom, United States, China, France, Spain
-
Epizyme, Inc.Swedish Cancer InstituteTerminatedFollicular LymphomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingFollicular LymphomaUnited States, Spain, Belgium, Japan, Australia, Germany, Italy, Netherlands, Norway, United Kingdom, Austria, France
-
Dana-Farber Cancer InstituteActive, not recruitingFollicular LymphomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Washington University School of MedicineTerminatedFollicular LymphomaUnited States
-
Gilead SciencesTerminatedFollicular LymphomaSpain, Italy, France, Poland, Israel, United Kingdom, Czechia, Romania, Australia, Canada
-
The Lymphoma Academic Research OrganisationRoche Pharma AGCompleted
-
Columbia UniversityTG Therapeutics, Inc.Terminated
-
CelltrionCompletedFollicular LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterCephalonTerminatedFollicular LymphomaUnited States
-
Cho Pharma Inc.Unknown
-
Lymphoma Study AssociationInstitute of Cancer Research, United Kingdom; Australasian Leukaemia and Lymphoma... and other collaboratorsCompletedFollicular LymphomaFrance, Thailand, Belgium, Spain, Argentina, Australia, Brazil, Colombia, Denmark, Netherlands, New Zealand, Peru
-
Hoffmann-La RocheCompletedFollicular LymphomaSerbia
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationWithdrawnLymphoma | Follicular Lymphoma
-
IRCCS Policlinico S. MatteoCompleted